73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n
Key insights from statistical modeling of cancer patient life expectancy

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t
CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna
Research links development of childhood leukaemia to mistakes by the immune system

Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the

Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the
Team pioneers cancer treatment that targets bone metastases while sparing bone

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells
Identifying key markers in pancreatic cancer progression using a new analysis pipeline

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino
Quest for better pancreatic cancer tests gains insights from survivor's data

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb
Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

by Thamarasee Jeewandara , Medical XpressAutophagy inhibition leads to a drop in the LIP in PDAC. (A) Autophagy was inhibited genetically or pharmacologically in PDAC cells, and the relative LIP was d

Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

by Thamarasee Jeewandara , Medical XpressAutophagy inhibition leads to a drop in the LIP in PDAC. (A) Autophagy was inhibited genetically or pharmacologically in PDAC cells, and the relative LIP was d
Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

by University of Los AndesExperimental workflow of MitoT to native and CAR engineered T cells. Credit:Journal of Translational Medicine(2024). DOI: 10.1186/s12967-024-05627-4In a pioneerin

Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

by University of Los AndesExperimental workflow of MitoT to native and CAR engineered T cells. Credit:Journal of Translational Medicine(2024). DOI: 10.1186/s12967-024-05627-4In a pioneerin
Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
How oxygen deprivation causes cancer cells to spread

How oxygen deprivation causes cancer cells to spread

byLeiden UniversityCredit: Pixabay/CC0 Public DomainIn breast cancer, metastasis rather than the primary tumor is the cause of death. A lack of oxygen in the tumor cells promotes this metastasis

How oxygen deprivation causes cancer cells to spread

byLeiden UniversityCredit: Pixabay/CC0 Public DomainIn breast cancer, metastasis rather than the primary tumor is the cause of death. A lack of oxygen in the tumor cells promotes this metastasis